ISRCTN75184582已完成未知
ephrectomy versus no nephrectomy for metastatic renal carcinoma
Medical Research Council (MRC) (UK)0 个研究点目标入组 120 人开始时间: 2001年2月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient should have locally operable disease and should be fit enough for nephrectomy
- •2. A renal tumour with clinical or radiological evidence of metastases
- •3. No previous malignancy (except non-melanotic skin cancer or in situ carcinoma of the cervix)
- •4. Written informed consent of the patient
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
1 期
Targeted therapy with or without nephrectomy in metastatic renal cell carcinomaPatients affected by non treated metastatic renal cell carcinomaMedDRA version: 21.0Level: PTClassification code 10073251Term: Clear cell renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-002240-14-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI270
已完成
不适用
Percutaneous Nephrostomy versus Emergency Percutaneous Nephrolithotomy of Sepsis Associated with Uretero-Pelvic Junctional Stone Impaction: A Randomized Controlled Trialsepsis associated with uretero-pelvic junctional stone impactionInfection - Other infectious diseasesRenal and Urogenital - Kidney diseaseACTRN12611000600943Chung Jing Wang45
进行中（未招募）
1 期
Treatment of metastatic renal cell carcinoma by dendritic cells vaccination.Metatastic renal cell carcinomaEUCTR2011-004391-11-CZMasaryk University30
招募中
不适用
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN TrialKidney CancerClear Cell Renal Cell Carcinoma MetastaticSynchronous NeoplasmNCT05753839Yonsei University40
招募中
不适用
Comparison outcomes of percutaneous nephrolithotomy in prone and flank positions in obese patientsIRCT20201108049303N1Tehran University of Medical Sciences60